Investigators employed genome-editing technologies in patient-derived organoids to study receptor tyrosine kinase KIT function in colorectal cancer in vitro and in vivo.
[Cell Death & Disease]
Home Newsletters Intestinal Cell News KIT Promotes Tumor Stroma Formation and Counteracts Tumor-Suppressive TGFβ Signaling in Colorectal...
